Fc-Based Cytokines: Prospects for Engineering Superior Therapeutics

Author： Jazayeri Jalal A.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.22, Iss.1, 2008-01, pp. : 11-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pro-Angiogenic Cytokines as Cardiovascular Therapeutics: Assessing the Potential

By Atluri Pavan   Woo Y. Joseph  

BioDrugs, Vol. 22, Iss. 4, 2008-01 ,pp. : 209-222

Adis International

Access to resources Recommend Favorite

Monomeric Fc Fusions: Impact on Pharmacokinetic and Biological Activity of Protein Therapeutics

By Dumont Jennifer A.   Low Susan C.   Peters Robert T.   Bitonti Alan J.  

BioDrugs, Vol. 20, Iss. 3, 2006-01 ,pp. : 151-160

Adis International

Access to resources Recommend Favorite

Optimizing Therapeutic Antibody Function: Progress with Fc Domain Engineering

By Kaneko Etsuji   Niwa Rinpei  

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

MicroRNA-Based Therapeutics for Cancer

By Wang Vivien   Wu Wei  

BioDrugs, Vol. 23, Iss. 1, 2009-01 ,pp. : 15-23

Adis International

Access to resources Recommend Favorite

Candidate Antibody-Based Therapeutics Against HIV-1

By Gong Rui   Chen Weizao   Dimitrov Dimiter S.  

BioDrugs, Vol. 26, Iss. 3, 2012-06 ,pp. : 143-162

Adis International

Access to resources Recommend Favorite